Anti-smuggling program gets $110 million in federal funds
An anti-narcotic and human trafficking effort, Operation Stonegarden, received $110 million in funding on July 24 to help curb the use of so-called “panga” boats for smuggling drugs and people onto the Central Coast. U.S. Representative Salud Carbajal, D-Santa Barbara, announced the appropriation of funds through fiscal year 2022 via the Department of Homeland Security’s Authorization Bill. Read More →
Moorpark company’s medicine bottles target elderly, opioid crisis
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta imaging device maker iCRco emerges from bankruptcy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port of Hueneme prefunding retiree health care debt
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Toad & Co. opens hybrid stores run by local retailers
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta medical device maker stocks are hot
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen partnering to develop new drugs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
